Index RUT
P/E -
EPS (ttm) -0.59
Insider Own 30.32%
Shs Outstand 181.22M
Perf Week 7.55%
Market Cap 219.11M
Forward P/E -
EPS next Y -0.41
Insider Trans -0.54%
Shs Float 146.80M
Perf Month 15.56%
Income -121.92M
PEG -
EPS next Q -0.10
Inst Own 30.21%
Short Float 15.70%
Perf Quarter 1.96%
Sales 68.08M
P/S 3.22
EPS this Y 35.38%
Inst Trans 0.81%
Short Ratio 12.35
Perf Half Y -6.31%
Book/sh 0.97
P/B 1.07
EPS next Y 1.19%
ROA -36.61%
Short Interest 23.05M
Perf Year -46.67%
Cash/sh 0.54
P/C 1.94
EPS next 5Y -
ROE -48.75%
52W Range 0.67 - 2.71
Perf YTD -3.70%
Dividend Est. -
P/FCF -
EPS past 5Y -
ROI -53.89%
52W High -61.62%
Beta 2.17
Dividend TTM -
Quick Ratio 3.24
Sales past 5Y 14.12%
Gross Margin 26.50%
52W Low 54.28%
ATR (14) 0.09
Dividend Ex-Date -
Current Ratio 5.13
EPS Y/Y TTM 25.05%
Oper. Margin -176.40%
RSI (14) 59.86
Volatility 8.11% 9.35%
Employees 225
Debt/Eq 0.12
Sales Y/Y TTM -7.11%
Profit Margin -179.08%
Recom 1.00
Target Price 3.38
Option/Short Yes / Yes
LT Debt/Eq 0.11
EPS Q/Q 37.08%
Payout -
Rel Volume 0.56
Prev Close 0.98
Sales Surprise 5.10%
EPS Surprise 41.67%
Sales Q/Q 14.09%
Earnings May 01 AMC
Avg Volume 1.87M
Price 1.04
SMA20 21.10%
SMA50 6.99%
SMA200 -11.22%
Trades
Volume 1,048,009
Change 5.81%
Date
Action
Analyst
Rating Change
Price Target Change
Mar-29-23 Initiated
UBS
Neutral
$2.25
Nov-29-22 Initiated
Oppenheimer
Outperform
$4.50
Oct-04-22 Initiated
B. Riley Securities
Buy
$9.50
Dec-17-21 Initiated
UBS
Neutral
$7
Jun-21-21 Initiated
Cowen
Outperform
$20
May-15-24 08:30AM
May-02-24 10:43AM
May-01-24 08:56PM
04:05PM
Apr-23-24 08:00AM
08:00AM
Loading…
Apr-17-24 08:00AM
Apr-15-24 08:30AM
Mar-27-24 09:00AM
Mar-20-24 08:00AM
Mar-19-24 08:30AM
Mar-15-24 05:35PM
Mar-06-24 08:30AM
Mar-05-24 09:40AM
Feb-29-24 11:36AM
Feb-28-24 04:05PM
08:00AM
Loading…
Feb-23-24 08:00AM
Feb-22-24 08:00AM
Feb-15-24 04:15PM
Feb-13-24 08:30AM
Jan-11-24 04:56PM
Jan-08-24 08:05AM
Jan-05-24 08:30AM
Dec-19-23 08:05AM
Dec-11-23 08:05AM
Nov-15-23 12:00PM
Nov-14-23 08:00AM
Nov-06-23 05:05PM
Nov-03-23 10:55AM
Nov-02-23 05:58PM
04:05PM
12:00PM
Loading…
Oct-31-23 12:00PM
10:01AM
Oct-27-23 12:00PM
Oct-24-23 08:10AM
Oct-18-23 04:14PM
Oct-10-23 07:00AM
Oct-09-23 08:05AM
Oct-04-23 08:05AM
Sep-14-23 08:05AM
Sep-09-23 01:03AM
Aug-05-23 07:14AM
Aug-03-23 09:15AM
08:00AM
Aug-02-23 05:05PM
Jul-27-23 05:25PM
Jul-17-23 10:24AM
Jul-03-23 06:17AM
Jun-05-23 12:30PM
May-11-23 09:25AM
08:05AM
May-09-23 07:25PM
10:12AM
May-04-23 06:05PM
Apr-27-23 10:03AM
08:30AM
Apr-24-23 08:10AM
Apr-17-23 06:41AM
Apr-11-23 09:40AM
Apr-10-23 05:22PM
Apr-03-23 04:05PM
Mar-29-23 03:36PM
Mar-14-23 07:42AM
Mar-08-23 05:00PM
Mar-02-23 08:25AM
Mar-01-23 05:00PM
Feb-28-23 11:25AM
08:00AM
Feb-22-23 05:00PM
Feb-16-23 09:40AM
Feb-13-23 08:30AM
Jan-23-23 11:34AM
Dec-27-22 09:37AM
Dec-19-22 08:00AM
Dec-14-22 08:00AM
Dec-06-22 05:00PM
Nov-18-22 06:20AM
Nov-09-22 05:40AM
Nov-06-22 07:31AM
Nov-05-22 05:39AM
Nov-03-22 08:00AM
Oct-24-22 08:00AM
Oct-20-22 02:41PM
Oct-07-22 05:33AM
Oct-05-22 06:20AM
Sep-29-22 05:04PM
Sep-20-22 08:30AM
Aug-30-22 06:41AM
Aug-24-22 08:10AM
Aug-16-22 08:35AM
Aug-12-22 09:40AM
Aug-08-22 04:05PM
Aug-03-22 07:30AM
Jul-21-22 04:45PM
Jul-20-22 07:20AM
May-24-22 08:00AM
May-13-22 01:59PM
(Simply Wall St.) +14.23%
08:00AM
May-12-22 04:05PM
May-09-22 09:54AM
May-05-22 08:00AM
Butterfly Network, Inc. designs a medical imaging device that reduces the cost of real-time and three-dimensional imaging and treatment. It develops and provides a whole-body portable ultrasound scanner called the iQ Device and related hosted, web-based application, application programming interfaces and platform services, which the firm offer to physicians or other licensed health care providers. Its products include iQ+ Ultrasound, Butterfly Enterprise and iQ Vet. The company was founded by Jonathan M. Rothberg on January 25, 2011 and is headquartered in Burlington, MA.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Getz Heather C EVP, CFO & COO May 03 '24 Sale 0.95 59,848 57,035 2,699,469 May 07 04:15 PM Stoica Andrei G Chief Technology Officer Apr 02 '24 Sale 1.00 1,778 1,782 1,497,558 Apr 04 04:30 PM Stoica Andrei G Chief Technology Officer Mar 25 '24 Sale 1.02 3,298 3,380 1,499,336 Mar 27 04:15 PM Getz Heather C EVP, CFO & COO Mar 11 '24 Sale 1.14 81,448 92,851 1,435,788 Mar 13 04:30 PM Stoica Andrei G Chief Technology Officer Mar 11 '24 Sale 1.14 76,498 87,208 889,675 Mar 13 04:31 PM Stoica Andrei G Chief Technology Officer Mar 05 '24 Sale 1.15 12,113 13,930 966,173 Mar 07 04:15 PM Getz Heather C EVP, CFO & COO Jan 05 '24 Sale 1.02 66,142 67,465 1,517,236 Jan 09 04:13 PM Stoica Andrei G Chief Technology Officer Jan 05 '24 Sale 1.02 35,612 36,324 978,286 Jan 09 04:12 PM Stoica Andrei G Chief Technology Officer Dec 26 '23 Sale 1.03 2,247 2,326 1,013,898 Dec 28 04:00 PM Stoica Andrei G Chief Technology Officer Dec 05 '23 Sale 0.99 7,935 7,895 1,016,145 Dec 07 04:49 PM Stoica Andrei G Chief Technology Officer Oct 03 '23 Sale 1.10 1,748 1,921 1,024,080 Oct 05 04:25 PM Stoica Andrei G Chief Technology Officer Sep 25 '23 Sale 1.21 3,300 3,977 1,025,828 Sep 27 06:58 PM Stoica Andrei G Chief Technology Officer Sep 06 '23 Sale 1.86 11,674 21,679 1,029,128 Sep 08 04:16 PM DEVIVO JOSEPH President & CEO Aug 30 '23 Buy 1.81 10,000 18,100 4,010,000 Sep 01 08:30 AM Getz Heather C EVP & Chief Financial Officer Jul 05 '23 Sale 2.19 65,577 143,482 1,383,378 Jul 06 05:43 PM Stoica Andrei G Chief Technology Officer Jul 05 '23 Sale 2.19 45,633 99,845 1,040,802 Jul 06 05:40 PM Weiss Lawrence T CLO, GC and Corp Sec Jul 05 '23 Sale 2.19 27,655 60,509 1,236,838 Jul 06 05:44 PM Stoica Andrei G Chief Technology Officer Jul 03 '23 Sale 2.34 1,687 3,941 1,086,435 Jul 06 05:40 PM Stoica Andrei G Chief Technology Officer Jun 23 '23 Sale 2.10 3,362 7,060 1,088,122 Jun 27 07:00 PM Stoica Andrei G Chief Technology Officer Jun 06 '23 Sale 2.25 11,661 26,269 1,091,484 Jun 08 04:15 PM Weiss Lawrence T CLO, GC and Corp Sec May 24 '23 Sale 2.22 52,296 116,076 1,264,493 May 26 04:17 PM
Index S&P 500
P/E 38.51
EPS (ttm) 1.94
Insider Own 1.54%
Shs Outstand 241.71M
Perf Week -1.32%
Market Cap 17.47B
Forward P/E 16.85
EPS next Y 4.44
Insider Trans -3.31%
Shs Float 229.78M
Perf Month -0.33%
Income 466.50M
PEG 5.20
EPS next Q 1.02
Inst Own 98.84%
Short Float 1.99%
Perf Quarter 2.34%
Sales 3.96B
P/S 4.41
EPS this Y 2.70%
Inst Trans -9.82%
Short Ratio 2.83
Perf Half Y 4.85%
Book/sh 20.76
P/B 3.61
EPS next Y 9.25%
ROA 5.14%
Short Interest 4.58M
Perf Year -9.12%
Cash/sh 9.34
P/C 8.01
EPS next 5Y 7.40%
ROE 9.20%
52W Range 64.02 - 83.13
Perf YTD 4.77%
Dividend Est. -
P/FCF 18.41
EPS past 5Y -
ROI 6.33%
52W High -9.95%
Beta 1.01
Dividend TTM -
Quick Ratio 3.29
Sales past 5Y 7.03%
Gross Margin 54.30%
52W Low 16.93%
ATR (14) 1.35
Dividend Ex-Date -
Current Ratio 3.97
EPS Y/Y TTM -35.24%
Oper. Margin 22.37%
RSI (14) 42.17
Volatility 1.69% 1.78%
Employees 6990
Debt/Eq 0.53
Sales Y/Y TTM -2.37%
Profit Margin 11.78%
Recom 2.00
Target Price 86.01
Option/Short Yes / Yes
LT Debt/Eq 0.52
EPS Q/Q -18.23%
Payout 0.00%
Rel Volume 1.00
Prev Close 75.65
Sales Surprise 1.60%
EPS Surprise 5.34%
Sales Q/Q -0.85%
Earnings May 02 AMC
Avg Volume 1.62M
Price 74.86
SMA20 -1.39%
SMA50 -1.81%
SMA200 2.42%
Trades
Volume 1,623,385
Change -1.04%
Date
Action
Analyst
Rating Change
Price Target Change
Apr-03-24 Upgrade
Citigroup
Neutral → Buy
$80 → $95
Jul-14-23 Upgrade
Needham
Hold → Buy
$95
Dec-07-22 Initiated
RBC Capital Mkts
Sector Perform
$75
Oct-13-22 Initiated
Mizuho
Buy
$75
Jul-20-22 Initiated
UBS
Neutral
$73
Jul-20-22 Downgrade
BofA Securities
Buy → Neutral
$81 → $75
Jul-18-22 Downgrade
BTIG Research
Buy → Neutral
Apr-25-22 Downgrade
Wells Fargo
Overweight → Equal Weight
$75
Apr-04-22 Downgrade
Evercore ISI
Outperform → In-line
$80
Dec-15-21 Downgrade
Citigroup
Buy → Neutral
$85 → $78
Oct-15-21 Resumed
Cowen
Outperform
$83
Oct-14-21 Initiated
Redburn
Neutral
Jul-06-21 Upgrade
Evercore ISI
In-line → Outperform
$78
Nov-20-20 Downgrade
Needham
Buy → Hold
Nov-05-20 Reiterated
Needham
Buy
$78 → $88
Jun-30-20 Upgrade
Cowen
Market Perform → Outperform
$64
Jun-03-20 Upgrade
Raymond James
Mkt Perform → Outperform
$62
Apr-30-20 Upgrade
SVB Leerink
Mkt Perform → Outperform
$62
Apr-30-20 Reiterated
Needham
Buy
$52 → $60
Apr-07-20 Upgrade
Wells Fargo
Equal Weight → Overweight
$48
Show Previous Ratings
May-13-24 09:30AM
May-09-24 08:21AM
May-07-24 11:12AM
09:00AM
May-04-24 01:07AM
12:40PM
Loading…
May-03-24 12:40PM
12:29PM
11:54AM
10:51AM
09:43AM
07:17AM
(Thomson Reuters StreetEvents)
May-02-24 09:59PM
08:58PM
08:00PM
05:45PM
05:10PM
Loading…
05:10PM
04:40PM
04:07PM
(Associated Press Finance)
04:01PM
Apr-30-24 06:27AM
Apr-29-24 05:58PM
04:05PM
11:44AM
09:16AM
Apr-25-24 10:01AM
Apr-22-24 05:45PM
Apr-21-24 08:30AM
Apr-19-24 11:30AM
09:00AM
Apr-17-24 11:01AM
05:45PM
Loading…
Apr-15-24 05:45PM
Apr-12-24 10:45AM
Apr-11-24 02:07PM
09:15AM
Apr-08-24 05:45PM
09:00AM
Apr-03-24 12:10PM
09:54AM
Apr-02-24 05:45PM
08:08AM
Mar-28-24 07:24AM
Mar-27-24 09:00AM
Mar-25-24 05:45PM
Mar-19-24 12:53PM
(The Wall Street Journal)
Mar-18-24 05:45PM
Mar-15-24 07:00PM
09:00AM
Mar-12-24 05:45PM
Mar-06-24 11:15AM
Mar-05-24 08:10AM
Mar-04-24 09:00AM
Feb-28-24 01:16AM
Feb-27-24 03:44PM
03:30PM
08:00AM
Feb-26-24 04:15PM
Feb-21-24 09:00AM
Feb-18-24 01:26PM
Feb-06-24 10:43AM
Feb-05-24 03:31PM
01:43PM
10:40AM
09:00AM
Feb-03-24 12:08AM
Feb-02-24 12:52PM
11:08AM
07:05AM
(Thomson Reuters StreetEvents)
Feb-01-24 05:35PM
05:30PM
05:21PM
04:45PM
04:10PM
(Associated Press Finance)
04:01PM
Jan-31-24 11:17AM
Jan-30-24 07:29PM
Jan-29-24 09:16AM
Jan-25-24 11:00AM
(The Wall Street Journal)
10:00AM
Jan-22-24 05:45PM
Jan-20-24 03:19PM
Jan-19-24 09:00AM
Jan-18-24 11:30AM
Jan-17-24 12:10PM
12:07PM
Jan-16-24 05:45PM
08:30AM
Jan-11-24 08:08AM
Jan-09-24 05:45PM
Jan-08-24 09:00AM
Jan-07-24 04:00PM
Jan-04-24 08:33AM
Jan-02-24 05:45PM
08:08AM
Dec-28-23 04:28AM
Dec-27-23 05:45PM
09:00AM
Dec-20-23 05:45PM
Dec-18-23 07:39AM
Dec-14-23 05:45PM
05:05PM
Hologic, Inc. engages in the development, manufacture, and supply of diagnostics products, medical imaging systems, and surgical products dedicated to serve the healthcare needs of women. It operates through the following segments: Breast Health, Diagnostics, GYN Surgical, and Skeletal Health. The Breast Health segment is involved in a portfolio of solutions for breast cancer care for radiology, pathology, and surgery. The Diagnostics segment focuses on products used to aid in the screening and diagnosis of human diseases. The GYN Surgical segment offers the NovaSure Endometrial Ablation System, the MyoSure Hysteroscopic Tissue Removal System, and the Fluent Fluid Management System. The Skeletal Health segment covers the Horizon DXA and the Fluoroscan Insight FD mini C-arm. The company was founded by S. David Ellenbogen and Jay A. Stein in 1985 and is headquartered in Marlborough, MA.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
GARRETT SCOTT T Director Mar 14 '24 Option Exercise 30.93 16,441 508,471 65,052 Mar 15 04:11 PM GARRETT SCOTT T Director Mar 14 '24 Sale 75.50 16,441 1,241,296 48,611 Mar 15 04:11 PM CRAWFORD SALLY Director Mar 08 '24 Option Exercise 26.74 9,039 241,703 141,966 Mar 11 06:41 PM CRAWFORD SALLY Director Mar 08 '24 Sale 76.40 9,039 690,607 132,927 Mar 11 06:41 PM Dockendorff Charles J Director Mar 08 '24 Sale 76.21 1,465 111,648 1,572 Mar 11 06:45 PM Oberton Karleen Marie Chief Financial Officer Jan 29 '24 Sale 75.00 14,940 1,120,500 103,916 Jan 30 04:08 PM Dockendorff Charles J Director Jan 02 '24 Option Exercise 38.44 7,551 290,260 17,482 Jan 04 04:09 PM Dockendorff Charles J Director Jan 02 '24 Sale 72.00 16,017 1,153,224 1,465 Jan 04 04:09 PM GARRETT SCOTT T Director Dec 11 '23 Sale 68.71 10,000 687,116 47,039 Dec 13 04:07 PM MACMILLAN STEPHEN P Chairman, President and CEO Nov 29 '23 Option Exercise 26.21 47,711 1,250,505 1,286,799 Dec 01 04:04 PM MACMILLAN STEPHEN P Chairman, President and CEO Nov 29 '23 Sale 70.41 47,711 3,359,188 1,239,088 Dec 01 04:04 PM Mitchell Essex D Div. President, GYN Surgical Nov 21 '23 Sale 71.85 7,500 538,890 12,827 Nov 24 04:02 PM GARRETT SCOTT T Director Jun 15 '23 Sale 79.72 10,000 797,240 57,039 Jun 20 05:03 PM
Index NDX, S&P 500
P/E 23.91
EPS (ttm) 3.43
Insider Own 7.02%
Shs Outstand 455.34M
Perf Week 0.99%
Market Cap 37.39B
Forward P/E 17.17
EPS next Y 4.77
Insider Trans -0.27%
Shs Float 424.41M
Perf Month -4.62%
Income 1.57B
PEG 2.08
EPS next Q 0.97
Inst Own 74.32%
Short Float 2.73%
Perf Quarter -1.51%
Sales 19.50B
P/S 1.92
EPS this Y 8.74%
Inst Trans -
Short Ratio 3.25
Perf Half Y 17.00%
Book/sh 16.23
P/B 5.05
EPS next Y 11.62%
ROA 4.85%
Short Interest 11.58M
Perf Year 9.32%
Cash/sh 5.61
P/C 14.59
EPS next 5Y 11.50%
ROE 22.33%
52W Range 62.35 - 94.50
Perf YTD 5.94%
Dividend Est. 0.09 (0.11%)
P/FCF 22.48
EPS past 5Y -2.54%
ROI 9.84%
52W High -13.32%
Beta 1.47
Dividend TTM 0.15 (0.18%)
Quick Ratio 0.79
Sales past 5Y 4.14%
Gross Margin 40.74%
52W Low 31.37%
ATR (14) 2.25
Dividend Ex-Date Apr 18, 2024
Current Ratio 1.01
EPS Y/Y TTM -8.71%
Oper. Margin 13.42%
RSI (14) 46.36
Volatility 2.30% 2.44%
Employees 51000
Debt/Eq 1.31
Sales Y/Y TTM 4.22%
Profit Margin 8.05%
Recom 1.82
Target Price 93.71
Option/Short Yes / Yes
LT Debt/Eq 1.15
EPS Q/Q 97.00%
Payout 3.97%
Rel Volume 0.55
Prev Close 80.52
Sales Surprise -3.15%
EPS Surprise -0.75%
Sales Q/Q -1.21%
Earnings Apr 30 BMO
Avg Volume 3.56M
Price 81.91
SMA20 -1.01%
SMA50 -5.61%
SMA200 7.45%
Trades
Volume 1,955,337
Change 1.73%
Date
Action
Analyst
Rating Change
Price Target Change
Feb-15-24 Initiated
HSBC Securities
Buy
$100
Feb-12-24 Upgrade
UBS
Sell → Neutral
$66 → $88
Nov-30-23 Initiated
Jefferies
Hold
$80
Nov-27-23 Downgrade
UBS
Neutral → Sell
$86 → $66
Sep-19-23 Initiated
Citigroup
Buy
$82
Aug-25-23 Initiated
Argus
Buy
$80
Aug-16-23 Initiated
Wells Fargo
Overweight
$90
Jul-31-23 Initiated
BofA Securities
Neutral
$82
Jun-27-23 Initiated
Morgan Stanley
Equal-Weight
$76
May-16-23 Initiated
Oppenheimer
Outperform
$97
Apr-26-23 Initiated
UBS
Neutral
$86
Apr-19-23 Initiated
Piper Sandler
Overweight
$95
Apr-10-23 Initiated
BTIG Research
Neutral
Mar-13-23 Initiated
Evercore ISI
Outperform
$90
Feb-17-23 Initiated
Mizuho
Buy
$90
Jan-19-23 Initiated
Redburn
Buy
Show Previous Ratings
May-15-24 12:08PM
May-14-24 09:00AM
May-13-24 02:25PM
May-10-24 09:00AM
May-07-24 08:19AM
08:05AM
Loading…
May-06-24 08:05AM
06:58AM
May-05-24 08:00AM
May-03-24 09:53AM
May-02-24 04:05PM
May-01-24 09:30AM
Apr-30-24 04:41PM
04:29PM
12:56PM
12:37PM
12:21PM
Loading…
12:21PM
(The Wall Street Journal)
10:54AM
10:32AM
(The Wall Street Journal)
09:30AM
07:30AM
06:20AM
Apr-29-24 09:00AM
Apr-28-24 08:00AM
Apr-25-24 09:13PM
Apr-24-24 11:34AM
09:30AM
Apr-23-24 05:50PM
01:38PM
Apr-22-24 06:00PM
11:10AM
07:07AM
Loading…
07:07AM
Apr-19-24 09:55AM
Apr-18-24 10:32AM
09:00AM
Apr-17-24 10:48AM
Apr-16-24 08:00AM
Apr-15-24 01:18PM
Apr-13-24 12:16PM
Apr-12-24 08:00AM
Apr-09-24 08:05AM
07:37AM
Apr-08-24 01:31PM
Apr-05-24 03:41PM
Apr-04-24 12:03PM
09:30AM
Apr-03-24 08:00AM
Apr-02-24 04:46PM
07:35AM
07:31AM
Apr-01-24 06:13PM
01:26PM
Mar-28-24 11:30AM
Mar-27-24 08:00AM
Mar-26-24 11:17AM
Mar-25-24 10:20AM
09:00AM
Mar-22-24 11:00AM
10:51AM
12:33AM
Mar-21-24 12:32PM
Mar-19-24 09:30AM
Mar-18-24 06:00PM
Mar-15-24 11:15AM
Mar-14-24 01:30PM
Mar-13-24 04:10PM
09:30AM
Mar-12-24 10:28PM
04:34PM
09:00AM
Mar-11-24 12:33PM
Mar-07-24 11:31AM
09:00AM
Mar-04-24 08:25AM
Mar-01-24 09:40AM
Feb-28-24 08:00AM
Feb-26-24 07:30AM
Feb-20-24 09:50AM
Feb-19-24 10:00AM
Feb-16-24 12:47AM
Feb-15-24 04:55PM
Feb-14-24 04:05PM
09:40AM
09:30AM
Feb-08-24 10:00AM
Feb-06-24 12:02PM
10:41AM
07:45AM
06:20AM
Feb-01-24 08:00AM
Jan-31-24 12:19PM
Jan-29-24 10:50AM
(The Wall Street Journal)
Jan-18-24 08:38AM
Jan-08-24 08:01AM
Dec-22-23 09:03AM
Dec-21-23 09:10AM
Dec-18-23 08:51AM
Dec-08-23 10:10AM
Dec-04-23 10:00AM
Nov-29-23 10:00AM
Nov-28-23 09:46AM
GE Healthcare Technologies, Inc. engages in the development and manufacturing of medical technology, pharmaceutical diagnostics, and digital solutions. It operates through the following segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics. The Imaging segment provides scanning devices, clinical applications, service capabilities and digital solutions. The Ultrasound segment offers screening, diagnosis, treatment, and monitoring of certain diseases. The Patient Care Solutions segment specializes in providing medical devices, consumables, services, and digital solutions. The Pharmaceutical Diagnostics segment supplies diagnostic agents to the global radiology and nuclear medicine community. The company was founded on May 16, 2022 and is headquartered in Chicago, IL.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Makela Jan CEO, Imaging May 15 '24 Option Exercise 74.35 66,955 4,978,229 130,303 May 15 07:15 PM Makela Jan CEO, Imaging May 15 '24 Sale 81.54 66,955 5,459,511 63,348 May 15 07:15 PM Makela Jan CEO, Imaging May 13 '24 Option Exercise 63.51 20,227 1,284,617 83,575 May 15 07:15 PM Makela Jan CEO, Imaging May 13 '24 Sale 81.57 20,227 1,649,916 63,348 May 15 07:15 PM Jimenez Frank R GC & Corporate Secretary May 01 '24 Buy 76.52 1,315 100,624 75,796 May 02 06:00 AM O'Neill Kevin Michael CEO, PDx Jul 31 '23 Option Exercise 40.40 13,275 536,310 37,300 Aug 02 04:05 PM O'Neill Kevin Michael CEO, PDx Jul 31 '23 Sale 77.32 15,609 1,206,949 24,025 Aug 02 04:05 PM Rott Roland CEO, Ultrasound Jun 08 '23 Sale 77.37 2,473 191,336 22,335 Jun 12 04:06 PM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite